Key Takeaways Hexiris Ophthalmics will present its OBi platform and first-in-human clinical findings at five ophthalmology ...

A Bayesian meta-analysis of 54 studies and more than 6.8 million cataract surgeries found antibiotic injection was associated with an approximately 79% reduction in the odds of postoperative ...

First Patient Enrolled in Phase 3 Trial of Ocugen's Gene Therapy for GA ...

X-Cel Specialty Contacts and Essilor Custom Contacts have launched Lunara, an FDA PMA-approved overnight orthokeratology lens made from 180 Dk Optimum Infinite material Lunara uses familiar tangential ...

The FDA granted De Novo marketing authorization to Avulux, establishing a new device classification for precision optical filters intended to decrease the impact of light sensitivity in patients with ...

Key Takeaways Orbis' first Flying Eye Hospital simulation project in Macau will train 70 ophthalmologists and nurses from ...

Key Takeaways Johnson & Johnson will host and participate in peer-to-peer educational programs at ESCRS 2026 covering ...

Hoya Vision Care and Nidek have renewed their global strategic partnership, extending a collaboration first established in 2023 with a new agreement that will automatically renew on a yearly basis.

https://eyewire.news/news/study-finds-glp-1-drugs-linked-to-lower-risk-of-legal-blindness-in-type-2-diabetes A large real-world study suggests that widely used GLP-1 ...

Science Corporation has commercially launched the PRIMA retinal implant in Europe after receiving CE mark approval, enabling availability across 30 European countries Clinical trial results published ...

Lupin and Tenpoint Therapeutics have entered into a partnership, providing VISUfarma exclusive rights to commercialize Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% in ...